Study of HRS-6257 in healthy volunteers
Part of Pain clinical trials.
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Men must weigh at least 50 kg, women at least 45 kg, and your BMI must be between 19 and 28.
- Women must not be pregnant or able to become pregnant during the study.
- You should not have donated more than 200 mL of blood in the last 6 months.
- You must have been off all prescription and over-the-counter medications, supplements, and herbal remedies for at least 14 days.
- You cannot have taken part in another investigational drug or vaccine study within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This early-stage trial tests a new investigational drug called KR25102 in healthy volunteers to see how safe it is and how the body processes it. The study also includes optional pain-sensitivity testing for some participants.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests a new investigational drug called HRS-2183 in healthy volunteers to see how safe it is and how the body processes it after a single dose and after multiple doses. It's a first step in studying this potential medicine.
This trial tests a new drug called HRS-6213. It is first given to healthy volunteers to check safety, and then to patients with solid tumors to see if it can help treat their cancer.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.